Clinical challenges in the treatment of a patient with decompensated heart failure and glucose-6-phosphate dehydrogenase deficiency (G6PDd)

Author:

Tojaga Nedim,Egholm Gro,Lund Hansen Dennis

Abstract

We present a case of a man in his 60s, known with glucose-6-phosphate dehydrogenase deficiency (G6PDd) and cor pulmonale, admitted to the department of cardiology due to cardiac decompensation and anaemia. The main complaint was dyspnoea. Echocardiography confirmed severe cor pulmonale with compression of the left ventricle. G6PDd has been linked with pulmonary hypertension which could contribute to aforementioned echocardiographic findings. Diuretics are the first line of treatment when it comes to cardiac decompensation, but sulfonamide diuretics can induce or exacerbate haemolysis in patients with G6PDd. Due to the respiratory distress of the patient, a treatment plan including sulfonamide diuretics was initiated in collaboration with the haematologists. Unfortunately, the patient died 2 days after admission. This case emphasises that not all cardiac patients can tolerate standard treatment with sulfonamide diuretics; despite this, they remain essential in the acute setting, and they are associated with foreseeable but only partly manageable complications in susceptible patients.

Publisher

BMJ

Subject

General Medicine

Reference29 articles.

1. Diagnosis and management of G6Pd deficiency;Frank;Am Fam Physician,2005

2. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives;Garcia;Trends Pharmacol Sci,2021

3. Anesthetic management in a patient with Glucose-6-phosphate dehydrogenase deficiency undergoing coblation adenoidectomy with septoplasty and turbinectomy;Dairi;J Med Cases,2019

4. Young type 1 diabetes mellitus (T1Dm) patient with glucose-6-phosphate dehydrogenase deficiency occurring hemolysis: a case report;Hou;Biomedical Research,2019

5. Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: From one crisis to another

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bendroflumethiazide/Furosemide/Spironolactone;Reactions Weekly;2023-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3